Blood thinner after C-Section: small study tests safety and feasibility

NCT ID NCT06118957

Completed Disease control Sponsor: University of Utah Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This pilot study tested whether giving the blood thinner enoxaparin after a C-section is feasible and safe. 64 women who had a C-section were randomly assigned to receive enoxaparin or no treatment for 14 days. The main goal was to see if enough women would join and complete the study, not to prove the drug prevents clots. Results will help design a larger trial.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: enoxaparin (a blood thinner)
What this could lead to: If this approach works, it could help prevent dangerous blood clots after C-section without major bleeding risks.
What could go wrong: This is a small pilot study (64 people) focused on feasibility, not on proving the drug works. The results may not apply to all women, and blood thinners carry a risk of bleeding.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for THROMBOEMBOLISM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Thromboembolism venous thromboembolism prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

THROMBOEMBOLISM

Contacts and locations

Locations

University of Utah

Salt Lake City, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.